Multi-center, Randomized, Double-blind, Placebo-controlled Trial of a Live Attenuated Influenza Vaccine in People Aged 3-17
Status: Recruiting
Location: See location...
Intervention Type: Other, Biological
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
To evaluate the protective effect 14 days after the live attenuated influenza vaccine; To evaluate the protective effect of vaccination with live attenuated influenza vaccine; To evaluate the safety of freeze-dried nasal spray live attenuated influenza vaccine; To evaluate the detoxification and genetic stability of lyophilized nasal spray vaccine. To evaluate the protective effect of novel coronavirus after 14 days of inoculation with the live attenuated influenza vaccine.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 3
Maximum Age: 17
Healthy Volunteers: t
View:
• Local residents aged between 3 and 17;
• People who signed the informed consent form and could actively cooperate with the study；
• Axillary body temperature of 37.0℃.
Locations
Other Locations
China
RECRUITING
Chifeng
Contact Information
Primary
Xibao Huang
hxb6407@163.com
027-87652133
Backup
Xiaoling Tian
txlingok@126.com
13848710296
Time Frame
Start Date: 2023-09-22
Estimated Completion Date: 2024-10-30
Participants
Target number of participants: 6080
Treatments
Experimental: Experimental group
Influenza Vaccine, Live, Nasal, Freeze-dried
Placebo_comparator: Placebo group
Sterile water for inhalation
Related Therapeutic Areas
Sponsors
Collaborators: Hu Bei province Center for Disease control and prevention, The Inner Mongolia Autonomous Region Center for Disease Control and Prevention
Leads: Changchun BCHT Biotechnology Co.